Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
J Cell Sci ; 117(Pt 2): 327-37, 2004 Jan 15.
Article in English | MEDLINE | ID: mdl-14676281

ABSTRACT

Studies employing human fetal intestine have yielded remarkable information on the role of polarized enterocytes in fat absorption. In this report, we investigated the intestinal expression, spatiotemporal distributions, ontogeny and function of the scavenger receptor, Class B, Type I (SR-BI) that plays a crucial role in cholesterol homeostasis. SR-BI was detected as early as week 14 of gestation in all gut segments and was almost entirely confined to the absorptive epithelial cells. By using immunofluorescence staining, the distribution of SR-BI rarely appeared as a gradient, increasing from the developing crypt to the tip of the villus. Western blot showed high levels of immunodetectable SR-BI in the duodenum, which progressively decreased toward the distal colon. The high-resolution immunogold technique revealed labelling mainly over microvilli of the enterocyte. SR-BI was not associated with caveolin-1 and was not detectable in caveolae. In order to define the role of SR-BI in intestinal cholesterol absorption, Caco-2 cells were transfected with a constitutive expression vector (pZeoSV) containing human SR-BI cDNA inserted in an antisense orientation. As noted by immunoblotting and Protein A-gold techniques, stable transformants contained 40, 60 and 80% the SR-BI level of control Caco-2 cells and exhibited a proportional drop in free cholesterol uptake without altering the capture of phospholipids or cholesteryl ester. Confirmation of these data was obtained in intestinal organ culture where SR-BI antibodies lowered cholesterol uptake. These observations suggest that the human intestine possesses a developmental and regional SR-BI pattern of distribution, and extends our knowledge in SR-BI-mediated cholesterol transport.


Subject(s)
Caveolins/metabolism , Cholesterol/metabolism , Enterocytes/metabolism , Intestinal Mucosa/metabolism , Animals , Caveolin 1 , Cells, Cultured , Enterocytes/ultrastructure , Humans , Intestinal Absorption , Intestines/cytology , Microscopy, Fluorescence , Microscopy, Immunoelectron
2.
J Cell Sci ; 116(Pt 1): 89-99, 2003 Jan 01.
Article in English | MEDLINE | ID: mdl-12456719

ABSTRACT

Studies were designed to test whether tyrosylation of high-density lipoprotein (HDL(T)) modifies its metabolic features. HDL(T) was less effective than native HDL in promoting cholesterol efflux from J774-AI macrophages. Cell association with fluorescent HDL(T)-apolipoprotein and the uptake of HDL(T)-[(3)H]cholesteryl hexadecyl ether were enhanced by 50% in comparison with native HDL. In addition, neutral cholesterol ester hydrolase (nCEH) activity in J774-AI, which controls the hydrolysis of cholesteryl ester stores to provide free cholesterol for cellular release, declined in the presence of HDL(T). In vitro displacement experiments revealed the ability of HDL(T) to compete with oxidized and acetylated LDL, known as ligands of scavenger receptor (SR) class B type I/II. Similarly, treatment with a blocking antibody to SR-BI/II reduced the cell association of HDL(T) and native HDL by 50%. The addition of polyinosinic acid, an inhibitor of SR class A, reduced the cell association of HDL(T) without affecting that of native HDL. These findings provide evidence that HDL(T) can compete with modified LDL, bind SR-BI/BII and internalize cholesterol ester. Furthermore, the impaired capacity of HDL(T) in promoting cholesterol efflux from J774-AI was accompanied by diminished nCEH and enhanced recognition by SR-AI/II, which appears to involve the transport of cholesterol into cells.


Subject(s)
CD36 Antigens/metabolism , Cholesterol/analogs & derivatives , Cholesterol/metabolism , Coronary Artery Disease/metabolism , Lipoproteins, HDL/metabolism , Macrophages/metabolism , Membrane Proteins , Receptors, Immunologic , Receptors, Lipoprotein , Animals , Antibodies , Apolipoproteins/pharmacology , Binding Sites/drug effects , Binding Sites/physiology , CD36 Antigens/drug effects , Cells, Cultured , Cholesterol/pharmacology , Cholesterol, LDL/metabolism , Coronary Artery Disease/physiopathology , Endocytosis/drug effects , Endocytosis/physiology , Macrophages/drug effects , Mice , Oxidative Stress/drug effects , Oxidative Stress/physiology , Poly I/pharmacology , Receptors, Scavenger , Scavenger Receptors, Class A , Scavenger Receptors, Class B , Sterol Esterase/pharmacology , Tyrosine/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL
...